Ohcanbohtosat - Xavier Padanilam

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study

    Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa:... Dahkki Norbert Ndjeka, Jonathon R. Campbell, Graeme Meintjes, Gary Maartens, H. Simon Schaaf, Jennifer Hughes, Xavier Padanilam, Anja Reuter, Rodolfo Romero, Farzana Ismail, Martin Enwerem, Hannetjie Ferreira, Francesca Conradie, Kogieleum Naidoo, Dick Menzies

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

    High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen Dahkki Norbert Ndjeka, Kathryn Schnippel, Iqbal Master, Graeme Meintjes, Gary Maartens, Rodolfo Romero, Xavier Padanilam, Martin Enwerem, Sunitha Chotoo, Nalini Singh, Jennifer Hughes, Ebrahim Variava, Hannetjie Ferreira, Julian te Riele, Nazir Ismail, Erika Mohr-Holland, Nonkqubela Bantubani, Francesca Conradie

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

    Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa Dahkki Karen Shean, Elizabeth M. Streicher, Elize Pieterson, Greg Symons, Richard N. van Zyl-Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul D. Wilcox, Tommie C. Victor, Paul D. van Helden, Martin Groubusch, Robin M. Warren, Motasim Badri, Keertan Dheda

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study

    Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sect... Dahkki Nazir Ismail, Shaheed Vally Omar, Harry Moultrie, Zaheda Bhyat, Francesca Conradie, Martin Enwerem, Hannetjie Ferreira, Jennifer Hughes, Lavania Joseph, Yulene Kock, Vancy Letsaolo, Gary Maartens, Graeme Meintjes, Dumisani Ngcamu, Nana Okozi, Xavier Padanilam, Anja Reuter, R Romero, H. Simon Schaaf, Julian te Riele, Ebrahim Variava, Minty van der Meulen, Farzana Ismail, Norbert Ndjeka

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

    Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study Dahkki Keertan Dheda, Karen Shean, Alimuddin Zumla, Motasim Badri, Elizabeth M. Streicher, Liesl Page‐Shipp, Paul A. Willcox, Martin Luther John, Gary Reubenson, Darshini Govindasamy, Michelle Wong, Xavier Padanilam, Alicia Dziwiecki, Paul D. van Helden, Sweetness Siwendu, Julie Jarand, Colin Menezes, Avril Burns, Thomas C. Victor, Robin M. Warren, Martin P. Grobusch, Martie van der Walt, Charlotte Kvasnovsky

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: